Ketamine Therapy Disqualifiers: Eligibility Guide

You've read about ketamine therapy helping people when nothing else worked. About 30% of people with major depression don't respond adequately to standard antidepressants, so if that's you, you're not alone. But somewhere between hope and action, a question stops you: Am I even eligible?

The short answer: Most people with treatment-resistant depression can safely receive ketamine therapy. Absolute disqualifiers are rare: aneurysmal vascular disease, uncontrolled high blood pressure, severe cardiovascular disease, active psychosis, pregnancy, and known ketamine allergy. Conditions that seem disqualifying, like controlled cardiovascular disease, history of psychosis when currently stable, or substance use disorder in stable recovery, often become treatable with proper screening and monitoring.

What Disqualifies You From Ketamine Therapy?

Disqualifiers fall into two categories: absolute contraindications and relative contraindications.

Absolute contraindications mean treatment cannot proceed safely regardless of circumstances. These are hard stops based on serious safety concerns documented by the FDA and major medical institutions.

Relative contraindications mean treatment requires additional evaluation, monitoring, or precautions. You're not automatically excluded—your care team implements safeguards tailored to your situation.

What Are the Absolute Medical Disqualifiers?

Six absolute medical contraindications make ketamine therapy unsafe. Treatment should not proceed due to serious safety concerns.

Cardiovascular Conditions

Uncontrolled hypertension tops the list. According to FDA prescribing information, ketamine poses serious risks for patients where blood pressure increases could be dangerous. Ketamine causes temporary blood pressure spikes that create serious risk of hypertensive crisis, stroke, or heart attack if your blood pressure is already dangerously high. "Uncontrolled" means your blood pressure isn't adequately managed. Controlled hypertension is different.

Aneurysmal vascular disease, arteriovenous malformation, or history of brain bleeding also disqualify you because blood pressure increases during ketamine could cause weakened vessels to rupture.

Severe cardiovascular disease including unstable angina, recent heart attack, or significant heart failure poses unacceptable risks. Patients over 50 showed an occurrence rate of almost 10% for new changes suggestive of myocardial ischemia immediately after ketamine administration.

Active Psychosis

Active psychosis is an absolute contraindication. Ketamine causes temporary alterations in consciousness. If you're already experiencing hallucinations or delusions, ketamine could worsen symptoms or trigger a severe psychotic episode. The key word is "active." A history of psychotic episodes that are now controlled requires individual assessment but doesn't automatically exclude you.

Pregnancy

Pregnancy disqualifies you because ketamine crosses the placenta, and animal studies show potential harm to developing fetuses.

Allergic Reactions

Known hypersensitivity to ketamine means you've had a previous allergic reaction. Re-exposure could trigger anaphylaxis.

Which Psychiatric Conditions Require Assessment?

Many psychiatric conditions require individual evaluation rather than automatic exclusion. Eligibility depends on current severity and stability rather than diagnostic labels alone.

Current Severity Matters Most

Active mania disqualifies you during the episode. You cannot safely engage in treatment. Once manic symptoms are controlled, you may become eligible.

Prominent current suicidal ideation with active planning requires immediate crisis intervention first. After stabilization, you may become eligible.

Current substance dependence typically means you can't receive treatment because active substance use makes it impossible to determine whether symptoms stem from mental health conditions or substance effects. However, stable recovery is different: documented sobriety (often 6–12 months) combined with engagement in recovery support does not automatically exclude you.

What Doesn't Automatically Exclude You

Having depression that hasn't responded to standard treatments is your qualification, not your exclusion.

History of psychosis that's currently stable requires thorough evaluation but doesn't automatically exclude you.

BPD diagnosis alone doesn't automatically disqualify you, though treatment requires careful clinical assessment and an established therapeutic relationship.

PTSD is not automatically disqualifying. Active severe dissociative symptoms may require modified protocols, but PTSD diagnosis alone doesn't disqualify you.

What Medication Interactions Should You Discuss?

Several medication classes require discussion during your clinical assessment.

Benzodiazepines present two concerns: additive CNS depressant effects and potential delays in ketamine's antidepressant effect. During your assessment, you'll discuss whether tapering benzodiazepines could improve your treatment outcomes.

Opioid pain medications substantially increase risks of respiratory depression. Your care team will work with you to adjust doses and provide enhanced monitoring.

MAOIs require extremely careful evaluation. Clinical research indicates concurrent use "should be pursued only with caution."

Stimulants can have additive effects on blood pressure. Your clinician will advise whether to hold your stimulant dose on treatment days.

SSRIs, SNRIs, and bupropion can be safely co-administered with ketamine.

What Are the Age Requirements?

Adults 18 and older meet age criteria for FDA-approved esketamine (Spravato) and off-label IV ketamine protocols.

Adults over 65 are not automatically excluded, though eligibility requires more extensive cardiovascular screening. Some research shows similar efficacy with lower starting doses, while other data suggests elderly patients may experience higher rates of adverse effects. Your care team will evaluate your individual risk profile.

Adolescents under 18 cannot receive FDA-approved ketamine outside clinical trials.

Does Substance Use History Disqualify You?

Active addiction typically disqualifies you. Stable recovery does not.

If you're currently using substances, focus on addiction treatment first. If you're in sustained recovery, you may be eligible. Many programs require 6–12 months of documented sobriety.

History of ketamine or esketamine abuse typically disqualifies you due to elevated relapse and safety concerns.

What Does an Ideal Candidate Look Like?

According to VA clinical guidelines, you're a good fit if you have:

• Depression unresponsive to at least two antidepressant trials
• Blood pressure controlled below 140/90 mmHg
• Stable cardiac function without recent heart events
• No active psychosis, mania, or delirium
• No current substance misuse except tobacco
• Ability to commit to the full treatment protocol

You don't need perfect health—you need conditions stable enough that ketamine's temporary cardiovascular effects won't destabilize them.

Still not sure? Our guide on whether ketamine therapy could be right for you may help.

How Does Innerwell Approach Eligibility?

When you apply to Innerwell's at-home program, a board-certified psychiatric clinician conducts comprehensive screening that evaluates your medical history, current medications, cardiovascular health, substance use history, and psychiatric stability.

This isn't ketamine dropped off with minimal supervision. According to professional nursing standards from APNA and clinical guidelines, every treatment plan involves rigorous interdisciplinary team oversight, structured pre-treatment screening, ongoing vital sign monitoring, and evidence-based integration with existing psychiatric care.

The medication opens a door; therapy helps you walk through it. Ketamine opens a window of neuroplasticity—a temporary period when your brain is more receptive to change. Integration sessions with licensed therapists help you process insights that emerge during treatment and translate them into lasting behavioral changes.

Innerwell is different in a few key ways:

• Licensed clinicians, not unlicensed guides. Every session is overseen by Master's or Doctoral-level licensed therapists with specialized training through partnerships like Fluence Training.
• Therapeutic support built in. Preparation sessions before treatment and integration therapy afterward help you process insights and translate them into lasting changes.
• At-home convenience. Treatment happens in your own space, reducing the logistical burden of clinic visits.
• Insurance partnerships. Sessions cost as low as $54 with insurance coverage available in California and New York.

Clinical outcomes demonstrate the effectiveness of this comprehensive approach: 69% reduction in depression symptoms after 10 weeks, 60% reduction in anxiety symptoms after 10 weeks, 87% of patients see improvement within 4 weeks, and 4.7 out of 5 star average patient rating.

Pricing and Access

Treatment plans include:

• Foundation Plan: $599 with insurance ($75/session) or $998 self-pay ($125/session) for 8 sessions
• Extended Plan: $1,299 with insurance ($54/session) or $1,999 self-pay ($83/session) for 24 sessions

Each plan includes comprehensive psychiatric evaluation, sublingual ketamine tablets delivered to your home, preparation sessions and integration therapy sessions, and ongoing clinical monitoring.

Take our free assessment to see if ketamine therapy might be right for you.

Frequently Asked Questions

Can I get ketamine therapy if I take blood pressure medication?

Yes. Controlled hypertension (below 140/90 mmHg with medication) doesn't automatically disqualify you. Your care team checks blood pressure before each treatment. Uncontrolled hypertension is the concern because ketamine temporarily raises blood pressure, which could trigger dangerous elevations without adequate baseline control.

Does a history of substance use disqualify me from ketamine therapy?

Active substance use typically disqualifies you, but stable recovery doesn't automatically exclude you. Many programs require 6–12 months of documented sobriety. History of ketamine abuse specifically typically disqualifies you due to misuse concerns.

What if I have bipolar disorder?

Bipolar disorder requires individual assessment. Active mania disqualifies you during the episode because you cannot safely engage in treatment. Once manic symptoms are controlled with mood stabilizers, you may become eligible. Your clinician will coordinate closely with your psychiatrist to ensure safe, effective treatment.

How long does the screening process take?

The complete screening process typically takes one to four weeks, depending on scheduling. Expect a comprehensive psychiatric evaluation, detailed medical history review, cardiovascular screening with blood pressure assessment, and laboratory testing.

What happens if I'm not eligible?

Your clinician will explain which conditions need attention before proceeding. Many exclusions are temporary. Uncontrolled blood pressure can be optimized through medication adjustments with your primary care doctor, and then you can reapply. Active psychiatric symptoms like mania or prominent suicidal thoughts require stabilization first but typically become eligible once controlled.